Some nuclear chemical aspects of medical generator nuclide production at the Los Alamos hot cell facility

Radiochimica Acta

Volumn 92, Issue 4-6, 2004, Pages 237-243

  Fassbender M ^a   Nortier, F M ^a   Phillips, D R ^a   Hamilton, V T ^a   Heaton, R C ^a   Jamriska, D J ^a   Kitten, J J ^a   Pitt, L R ^a   Salazar, L L ^a   Valdez, F O ^a   Peterson, E J ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

109Cd; 68Ge; 82Sr; 88Zr; Charged paticle induced reactions; Generator nuclide parent; Radiochemical separation; Reaction cross section; Thick target yield

Indexed keywords

CADMIUM 109; GERMANIUM; GERMANIUM 68; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; STRONTIUM 82; UNCLASSIFIED DRUG; ZIRCONIUM; ZIRCONIUM 88;

ARTICLE; BATCH PROCESS; COMPUTER MODEL; HOT CELL FACILITY; INDUSTRIAL PRODUCTION; NUCLEAR MEDICINE; NUCLEAR REACTION; NUCLEAR REACTOR; PARTICLE RADIATION; PROCESSING; PROCESSING YIELD; PURIFICATION; RADIOACTIVITY; RADIOCHEMISTRY; REACTION ANALYSIS; THEORY; THICK TARGET YIELD; UNITED STATES;

EID: 3142712242     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.92.4.237.35596     Document Type: Article

References (61)

1. Cheson, B. D.: Radioimmunotherapy of non-Hodgkin lymphomas. Blood 101(2), 391 (2003).
2. (a) Firestone, R. B., Chu, S. Y. F.: Table of Isotopes. (Baglin, C. M., ed.) Wiley, New York (1998);
3. th Edn., John Wiley & Sons, Inc., New York, Chichester, Brisbane, Toronto (1978).
4. Faßbender, M., Shubin, Y. N., Lunev, V. P., Qaim, S. M.: Experimental studies and nuclear model calculations on the formation of radioactive products formed in the interaction of medium energy protons with copper, zinc and brass: estimation of collimator activation in proton therapy facilities. J. Appl. Radiat. Isot. 48, 1221 (1997).
5. Andersen, H. H., Ziegler, J. F.: Hydrogen Stopping Powers and Ranges in All Elements. Vol. 2 of The Stopping and Ranges of Ions in Matter. Pergamon Press, New York (1977).
6. Qaim, S. M.: Production of radiotracers for PET. Proceedings of the Workshop on ion and slow positron beam utilization, Ion and slow positron beam utilisation (15-17 Sep 1998: Costa da Caparica (Portugal)), OECD-NEA (1999) p. 217.
7. Hofmann, M. M., Boerner, A. R., Maecke, H. R., Otto, D., Kalbacher, H., Knapp, W.: Clinical application of Ga-68-DOTATOC PET (SMS PET) in the detection of small metastases of neuroendocrine tumours. J. Nucl. Med. 43(5), Suppl.S, 311P (2002).
8. Smith-Jones, P. M., Afroze, A., Zanzonico, P., Tait, J., Larson, S. M., Strauss, H. W.: Ga-68 labelling of Annexin-V: Comparison to 99-Tc-Annexin-V and Ga-67-Annexin. J. Nucl. Med. 44(5), Suppl.S, 49P (2203).
9. Henze, M., Dimitrakopoulou-Strauss, A., Schuhmacher, J., Hipp, P., Maecke, H. R., Strauss, L. G., Haberkorn, U.: Kinetic analysis of Ga-68-DOTA(0)-D phe(1)-tyr(3)-oc-treotide (DOTATOC) in untreated meningiomas. J. Nucl. Med. 44(5), Suppl.S, 244P (2003).
10. Stoll, H. P., Hutchins, G. D., Winkle, W. L., Nguyen, A. T., Appledorn, C. R., Janzen, I., Seifert, H., Rube, C., Schieffer, H., March, K. L.: Advantages of short-lived positron-emitting radioisotopes for intracoronary radiation therapy with liquid-filled balloons to prevent restenosis. J. Nucl. Med. 42(9), 1375 (2001).
11. Henze, M., Schuhmacher, J., Hipp, P., Kowalski, J., Becker, D. W., Doll, J., Macke, H. R., Hofmann, M., Debus, J., Haberkorn, U.: PET imaging of somatostatin receptors using [(68)GA]DOTA-D-Phe(1)-Tyr(3)-octreotide: First results in patients with meningiomas, J. Nucl. Med. 42(7), 1053 (2001).
12. Nagame, Y., Nakahara, H., Furukawa, M..: Excitation functions for alpha-particles and He-3 particles included reactions on zinc. Radiochim. Acta 46(1), 5 (1989).
13. 71Ga with 13-56MeV protons. Nucl. Phys. 43, 500 (1963).
14. Levkovski, V. N.: Activation cross sections for the nuclides of medium mass region (A = 40-100) with protons and a-particles at medium (E = 10-50 MeV) energies. (Experiment and systematics) Inter-Vesti, Moscow (1991).
15. Jamriska, D. J., Carty, J., Peterson, E. J., Hardy, C. J.: Spallation production of neutron deficient radioisotopes in North America. Second international conference on isotopes. Conference proceedings, International Conference on Isotopes 2.: 12-16 Oct 1997: Sydney (Australia), Report No. INIS-AU-0011(v.1); DE99604260; CONF-9710130.
16. Qaim, S. M., Tárkányi, F. T., Oblozinsky, P., Gul, K., Hermanne, A., Mustafa, M. G., Nortier, F. M., Scholten, B., Shubin, Y., Takacs, S., Zhuang, Y.: Charged-particle cross section database for medical radioisotope production. http://www-nds.iaea.or.at/medical/ (2001).
17. Votaw, J. R., White, M.: Comparison of 2-dimensional and 3-dimensional cardiac Rb-82 PET studies. J. Nucl. Med. 42(5), 701 (2001).
18. de Kemp, R. A., Ruddy, T. D., Hewitt, T., Dalipaj, M. M., Beanlands, R. S. B.: Detection of serial changes in absolute myocardial perfusion with Rb-82 PET, J. Nucl. Med. 41(8), 1426 (2000).
19. Lin, J. W., Laine, A. F., Akinboboye, O., Bergmann, S. R..: Use of wavelet transforms in analysis of time-activity data from cardiac PET. J. Nucl. Med. 42(2), 194 (2001).
20. Tallet, J., Eisner, R. L., Mansour, C. S., Patterson, R. E.: Ability of PET Rb-82 myocardial perfusion imaging to predict death. J. Nucl. Med. 44(5), Suppl.S, 2P (2003).
21. Cullom, S. J., Meyer, A. F., Case, J. A., McGhie, I. A., Bateman, T. M.: Preliminary evaluation of LSO-based PET for ECG-gating of rest/stress Rb-82 perfusion studies. J. Nucl. Med. 43(5), Suppl.S, 197P (2002).
22. Machac, J., Chen, H., Almeida, O. D., Krynyckyi, B. R., Kim, C. K., Knesaurek, K.: Comparison of 2D and high dose and low dose 3D gated myocardial Rb-82 PET imaging. J. Nucl. Med. 43(5), Suppl.S, 188P (2002).
23. Pretorius, P. H., Fung, L. T., Schell, C. P., King, M. A.: Measurement of effective functional renal volume of small kidneys using Rb-82 and a hybrid gamma camera. J. Nucl. Med. 43(5), Suppl.S, 352P (2002).
24. Dou, Y., Eisner, R. L., Streeter, J. R., Halkar, R. K., Mansour, C. S., Williams, B. R., Sigman, S., Patterson, R. E.: Rb-82 positron emission tomography identifies left main or three vessel cornory disease. J. Nucl. Med. 43(5), Suppl.S, 175P (2002).
25. Phillips, D. R., Carty, J. S., Sosnowski, K. M., Hanekom, J., van der Walt, T. N., Nortier, F. M., Konyakhin, N. A., Kokhanyuk, V. M., Zhuikov, B. L., Kurczak, S., Mausner, L. F., Kolsky, K. L., Heaton, R. C., Pitt, L. R., Salazar, L. L., Valdez, F. O., Kitten, J. J., Hamilton, V. T., Jamriska, D. J., Taylor, W. A., Peterson, E. J.: Production of strontium-82 for the Cardiogen® PET generator: a project of the Department of Energy Virtual Isotope Center. Radiochim. Acta 88(3-4), 149 (2000).
26. Tárkányi, F., Qaim, S. M., Stoecklin, G.: Excitation-functions of He-3-particle and alpha-particle induced nuclear-reactions on natural krypton - production of Sr-82 at a compact cyclotron. Appl. Radiat. Isot. 39(2), 135 (1988).
27. Tárkányi, F., Qaim, S. M., Stoecklin, G.: Excitation-functions of He-3-particle and alpha-particle induced nuclear-reactions on enriched Kr-82 and Kr-83. Radiochim. Acta 43(4), 185 (1988).
28. Tárkányi, F., Qaim, S. M., Stoecklin, G.: Excitation-functions of He-3-particle and alpha-particle induced nuclear-reactions on natural krypton with special reference to the production of Sr-82. Appl. Radiat. Isot. 41(1), 91 (1990).
29. Ido, T., Hermanne, A., Ditroi, F., Szucs, Z., Mahunka, I., Tárkányi, E: Excitation functions of proton induced nuclear reactions on Rb-nat from 30 to 70MeV. Implication for the production of Sr-82 and other medically important Rb and Sr radioisotopes. Nucl. Instrum. Methods Phys. Res. B 194(4), 369 (2002).
30. Zaitseva, N. G., Deptula, C., Knotek, O., Khan, K. S., Mikolaewski, S., Mikeh, P., Rurarz, E., Khalkin, V. A., Konov, V. A., Popinenkova, L.M..: Cross-sections for the 100MeV proton-induced nuclear reactions and yields of some radionuclides used in nuclear medicine. Radiochim. Acta 54(2), 57 (1991).
31. 82Sr. Appl. Radiat. Isot. 56(5), 685 (2002).
32. 82Sr production at Los Alamos National Laboratory. Appl. Radiat. Isot. 38, 175 (1987).
33. Alvarez-Diez, T. M., de Kemp, R., Beanlands, R., Vincent, J.: Manufacture of strontium-82/rubidium-82 generators and quality control of rubidium-82 chloride for myocardial perfusion imaging in patients using positron emission tomography. Appl. Radiat. Isot. 50, 1015 (1999).
34. 82Sr from a metallic Rb target in a 100 MeV proton beam. Radiochemistry 36(6), 548 (1995).
35. Bumbalova, A., Dejmkova, E., Riecanska, E., Harangozo, M., Havranek, E.: Multielement XRF-analysis of blood from patients with dilated cardiomyopathy. J. Radioanalyt. Nucl. Chem. Lett. 153(4), 257 (1991).
36. Aro, A. C. A., Todd, A. C., Amarasiriwardena, C., Hu, H.: Improvements in the calibration of Cd-109-K X-ray-fluorescence systems for measuring bone lead in-vivo. Phys. Med. Biol. 39(12), 2263 (1994).
37. Green, S., Bradley, D. A., Palethorpe, J. E., Mearman, D., Chettle, D. R., Lewis, A. D., Mountford, P. J., Morgan, W. D.: An enhancedsensitivity K-shell X-ray fluorescence technique for tibial lead determiation. Phys. Med. Biol. 38(3), 389 (1993).
38. Williams, K. A.: Measurement of ventricular function with radionuclide techniques. Curr. Cardiol. Rep. 5(1), 45 (2003).
39. Port, S. C.: Recent advances in first-pass radionuclide angiography. Cardiol. Clin. 12(2), 359 (1994).
40. Steinkrueger, F. J., Wanek, P. M., Moody, D. C.: Cd-109-Ag-109m biomedical generator. J. Labelled Compd. Radiopharm. 21(11), 1281 (1984).
41. Wanek, P. M., Moody, D. C., Steinkruger, F. J.: Biomedical silver - 109m isotope generator. US Patent Application 6-708, 625.
42. 109Sn in proton bombardment of indium up to 200MeV. Appl. Radiat. Isot. 42(11), 1105 (1991).
43. Blaser, J. P., Boehm, F., Marmier, P., Scherrer, P.: Fonctions d'Excitation de la Reaction (p, n). Part I,II,III, Helv. Phys. Acta 24(3), 441 (1951).
44. 139La from 5 to 10.5MeV. Phys. Rev. 128, 280 (1962).
45. Read, J. B. J., Miller, J. M.: Nuclear-structure effects in high-energy (p, n) reactions. Phys. Rev. 140, B623 (1965).
46. 110m Ag reactions. Nucl. Instrum. Methods Phys. Res. B 68, 145 (1992).
47. Meijs, W. E., Haisma, H. J., Klok, R. P., van Gog, F. B., Kievit, E., Pinedo, H. M., Herscheid, J. D. M.: Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice. J. Nucl. Med. 38, 122 (1997).
48. Kobayashi, H., Wu, C. C., Kim, M. K., Paik, C. H., Carrasquillo, J. A., Brechbiel, M. W.: Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody. Bioconj. Chem. 10(1), 103 (1999).
49. 88Zr, Appl. Radiat. Isot. 42(2), 208 (1991).
50. 82Sr and other spallation products from proton irradiated molybdenum. Am. Chem. Society 205, 50 (1993).
51. 88Y at a small-sized cyclotron. Radiochim. Acta 90, 845 (2002).
52. 88Zr recovery from proton irradiated Ga/Nb capsules. J. Radioanal. Nucl. Chem, in press.
53. Mukherjee, S., Singh, N. L., Rao, A. V. M., Chaturvedi, L., Singh, P. P.: Analysis of the excitation functions from alpha particle induced reactions up to 120MeV. Physica Scripta 55, 409 (1997).
54. Zweit, J., Downey, S., Sharma, H. L.: Production of no-carrier-added zirconium-89 for positron emission tomography. Appl. Radiat. Isot. 42(2), 199 (1991).
55. Das, S. K., Nair, A. G.C, Chatterjee, R. K., Guin, R., Saha, S. K.: The performance of a new Hf-172-Lu-172 generator. Appl. Radiat. Isot. 47(7), 643 (1996).
56. Romo, A. S. M. A., Nassiff, S. J., Rodriguez Sierra, D. A., Sonzogni, A. A.: Nuclear reactions induced by alpha particles on natural ytterbium. Radiochim. Acta 57(2/3), 57 (1992).
57. 172Lu. Int. J. Nucl. Med. Biol. 5(1), 11 (1978).
58. Daniels, R. J., Grant, P. M., O'Brien, H. A.: Radionuclides from proton-induced spallation reactions for biomedical applications. 2. Hf-172 production, recovery, and purification from tantalum targets. Am. Chem. Soc. 175, 76 (1978).
59. Szweryn, B., Schaedel, M., Schausten, B., Bruechle, W.: Radiochemical Separations of Target-like Reaction Products from Au-, Pt-, and Th-targets after Irradiation with GeV Protons. Gesellschaft fuer Schwerionenforschung m.b.H., Darmstadt, Report No. GSI-88-48-Prepr.; DE88755401.
60. 194Au: half-life and emission probabilities. Appl. Radiat. Isotope 43(5), 647 (1992).
61. Jamriska, D. J., Carty, J., Peterson, E. J.: Spallation production of neutron deficient radioisotopes in North America. Los Alamos Report No. LA-UR-97-3309 (1997).